M&A conference or a CDMO/CMO event? Yes! Read our March column from Today’s Medical Developments Magazine.

In their first column of 2023 in Today’s Medical Developments Magazine, CEO Florence Joffroy-Black and Co-Founder/Managing Director Dave Sheppard share some of the key observations from the 2023 JPM Healthcare Conference.

Support those affected by the February 6th Earthquake in Turkey and Syria.

Co-Founder/Managing Director Dave Sheppard is one of several members of the MPO editorial advisory board sharing their thoughts on the headlines of 2022 and what’s coming in 2023 for MPO Magazine.

CEO & President Florence Joffroy-Black contributes her thoughts in Orthopedic Design & Technology Magazine’s Orthopedic M&A 2022 Year in Review.

Will MedTech M&A in 2023 remain a sellers market? Currently, compared to past years, 2022 investments are at historically average levels.

Our healthcare industry is in the midst of a digital transformation. In MedTech business terms, the impacts of Digital Health Tech are still sometimes ambiguous due to a combination of misalignment on both terminology and various stages of technology adoption. In this article we highlight some of segments within Digital Health Tech for our TMD community to reference as we go forward.

As M&A advisors in MedTech, we’re often asked to share the recipe for negotiating an exit deal with a larger strategic industry player. There are many ingredients in this recipe, but only about a half-dozen are key to sealing an agreement with a larger OEM. This column details some of the most important points to consider in developing an early-stage company.

It is necessary to understand the different types of buyers and how they can get the most value for their enterprises.

Pathway to strategic partnerships or exit for early-stage or middle-market MedTech companies.

Top 6 ways MedTech’s giants influence all of us.

While there are a myriad of issues affecting healthcare development and delivery, the most impactful remain more or less the same.